Advertisement
U.S. Markets close in 5 hrs 22 mins

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.1200+0.4600 (+12.57%)
As of 10:05AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close3.6600
Open3.7928
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.6600 - 4.3101
52 Week Range3.5100 - 14.8000
Volume33,376
Avg. Volume27,165
Market Cap3.767M
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-6.6400
Earnings DateMay 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

    NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the “Merger Agreement”) regarding a business combination with KE Sdn. Bhd. (“KE”). The Merger Agreement was approved by Titan’s board of directors (the “Board”). If the Merger Agreement is approved by the stockholders of Titan and KE (and the other closing conditions are satisfied or waived in accordance

  • Associated Press Finance

    Titan Pharmaceuticals: Q2 Earnings Snapshot

    SAN FRANCISCO (AP) — Titan Pharmaceuticals Inc. TTNP) on Thursday reported a loss of $2.1 million in its second quarter. On a per-share basis, the San Francisco-based company said it had a loss of $2.29.